Thursday, 26 February 2015
South Carolina court orders Johnson & Johnson to pay $136 million in Risperdal case
(Reuters) - South Carolina's Supreme Court ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury's finding that the drugmaker's Janssen unit had improperly marketed its anti-psychotic drug Risperdal and concealed its risks.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment